Signaturefd LLC Sells 1,239 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Signaturefd LLC cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.7% in the fourth quarter, HoldingsChannel reports. The fund owned 20,457 shares of the healthcare conglomerate’s stock after selling 1,239 shares during the period. Signaturefd LLC’s holdings in UnitedHealth Group were worth $10,348,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also added to or reduced their stakes in UNH. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $25,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. Promus Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth $32,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the third quarter valued at $37,000. Finally, Pillar Financial Advisors LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $40,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

NYSE UNH opened at $488.52 on Monday. The firm’s 50 day moving average price is $511.36 and its 200-day moving average price is $549.80. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market cap of $446.85 billion, a PE ratio of 31.52, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the business posted $5.83 EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.72%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s payout ratio is presently 54.19%.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Piper Sandler cut their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Stephens lifted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.